Compare CHCT & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CHCT | TLRY |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medicinal Chemicals and Botanical Products |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 514.6M | 570.4M |
| IPO Year | 2015 | 2018 |
| Metric | CHCT | TLRY |
|---|---|---|
| Price | $15.24 | $4.40 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | $18.00 | ★ $72.33 |
| AVG Volume (30 Days) | 202.3K | ★ 4.5M |
| Earning Date | 05-05-2026 | 04-01-2026 |
| Dividend Yield | ★ 11.07% | N/A |
| EPS Growth | ★ 134.78 | 55.69 |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $121,195,000.00 | N/A |
| Revenue This Year | $9.06 | $8.79 |
| Revenue Next Year | $8.61 | $19.98 |
| P/E Ratio | $253.00 | ★ N/A |
| Revenue Growth | ★ 4.67 | N/A |
| 52 Week Low | $13.23 | $0.62 |
| 52 Week High | $19.17 | $15.70 |
| Indicator | CHCT | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 22.29 | 48.77 |
| Support Level | $14.02 | $4.20 |
| Resistance Level | $17.45 | $4.85 |
| Average True Range (ATR) | 0.52 | 0.23 |
| MACD | -0.29 | 0.08 |
| Stochastic Oscillator | 2.90 | 55.51 |
Community Healthcare Trust Inc is an integrated healthcare real estate company in the United States. The company owns and acquires, or finances, real estate properties that are leased to hospitals, doctors, healthcare systems, or other healthcare service providers in non-urban markets. The company derives the majority of its revenues from its real estate property and mortgage notes portfolio. The company's rental and mortgage interest income is recognized based on contractual arrangements with its tenants and borrowers.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.